First of all @The Yankee, so good to see you back contributing....

  1. 1,326 Posts.
    lightbulb Created with Sketch. 1540
    First of all @The Yankee, so good to see you back contributing. Experience tells us you have much to offer. Please keep us informed of what's happening in USA. Welcome.

    Now, as to Gilead's Remdesivir, the name tells me it probably is an anti-viral. Something to kill Covid-19. Good luck to them. We need it. Not competition for MSB's Remstemcel-L,

    I'm sure you know but some here might need the focus, Remstemcel-L treats ARDS. ARDS is the highly fatal condition that some sufferers from Covid-19 might acquire. And many of them will die. Not every one who contracts Covid-19 will get ARDS. But there will be plenty enough to make it a big earner for MSB.

    And Covid-19 is not the only thing that causes ARDS. Plenty of market and marketing for MSB.

    I think the big gainer for MSB from this is the commanding of respect from fundies. They will see the credibility of the science, the colossal breadth of application to all health issues, and the genius of SI and associates who have tied this up in multiple patents in every significant market in the world.

    Is there anyone who cannot see this new paradigm unfolding?
    Last edited by benelong: 10/03/20
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.70
Change
0.030(1.80%)
Mkt cap ! $2.172B
Open High Low Value Volume
$1.67 $1.74 $1.67 $6.647M 3.897M

Buyers (Bids)

No. Vol. Price($)
3 44280 $1.69
 

Sellers (Offers)

Price($) Vol. No.
$1.70 26847 2
View Market Depth
Last trade - 16.10pm 15/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.